BEAM Competitors & Alternatives
Compare Beam Therapeutics Inc with similar stocks in the same industry
Biotechnology
BEAM
Main Stock$26.81
Tradestie Score
57
Market Cap
$2.44B
Revenue Growth
3.2%
Analyst Upside
+90.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$34.14
|
$3.31B | - | 59 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$26.39
|
$3.09B | - | 58 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$28.69
|
$3.08B | - | 53 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$39.64
|
$3.03B | - | 56 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$53.71
|
$3.02B | - | 56 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$62.93
|
$3.01B | - | 52 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$24.19
|
$2.89B | - | 50 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$26.53
|
$2.85B | - | 48 | Compare |
More BEAM Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry